Treatment
Direct acting antivirals (DAAs) are the most effective treatment
option for people with hepatitis C and are the NICE and NHS England
recommended medications.
- Choice of DAA is dependent on the type of hepatitis c virus you
have (genotype), past treatment response, the level of active virus
in your body (viral load) and if there is cirrhosis (degree of
liver damage shown by scarring of the liver).
- Ribavirin may be added to the treatment when patients have a
high viral load or more advanced liver disease, to increase the
chance of achieving a cure.
- Drug interactions are very important to consider in people
receiving DAA therapy, as they can sometimes affect how well the
treatment works (eg oral contraceptives) or contribute to side
effects. It is essential that all co-prescribed medication is first
checked for drug to drug interactions using https://www.hep-druginteractions.org/.
- DAAs and ribavirin cannot be prescribed safely during pregnancy
and some drugs can affect conception also. These risks will be
discussed with patients prior to starting treatment.
Common Medications
Elbasvir/Grazoprevir 50mg/100mg (Zepatier®)
- Zepatier is a two-drug combination in a single tablet. It is 1
tablet taken orally and swallowed whole once daily. Treatment
durations are 12 or 16 weeks depending on viral load and
genotype.
- Side effects are minimal but some people experience headache,
nausea, diarrhoea, insomnia and fatigue (lack of energy).
- This drug may not be suitable if you are taking anticoagulants
(such as rivaroxaban or apixaban), epilepsy medications or some
cholesterol-lowering drugs (statins) but people will be assessed on
an individual basis.
Glecaprevir/Pibrentasvir 100mg/40mg
(Maviret®)
- Maviret is a two-drug combination in a single tablet. It is 3
tablets taken orally and swallowed whole with food once a day.
Treatment duration is usually 8 weeks; courses up to 16 weeks are
needed occasionally.
- Side effects are minimal but some people experience headache,
nausea and fatigue (lack of energy).
- This drug may not be suitable if you are taking anticoagulants
(such as rivaroxaban or apixaban), epilepsy medications or some
cholesterol lowering drugs (statins) but people will be assessed on
an individual basis.
Sofosbuvir/Ledipasvir 400mg/90mg (Harvoni®)
- Harvoni is a two-drug combination in a single tablet. It is 1
tablet taken orally and swallowed whole once a day. Treatment
durations are 8 or 12 weeks depending on viral load, genotype and
past treatment response.
- Side effects are minimal but some people experience headaches
and fatigue (lack of energy).
- This drug may not be suitable if you are taking amiodarone,
anticoagulants (such as rivaroxaban or apixaban), epilepsy
medications or some cholesterol lowering drugs but people will be
assessed on an individual basis. If you have problems with your
kidneys this drug may not be suitable.
Sofosbuvir/Velpatasvir 400mg/100mg
(Epclusa®)
- Epclusa is a two-drug combination in a single tablet. It is 1
tablet taken orally and swallowed whole once a day. Treatment
duration is usually 12 weeks depending on viral load, genotype and
past treatment response.
- Side effects are minimal but some people experience headaches
and fatigue (lack of energy).
- This drug may not be suitable if you are taking amiodarone,
anticoagulants (such as rivaroxaban or apixaban), epilepsy
medications or some cholesterol lowering drugs (statins) but people
will be assessed on an individual basis. If you have problems with
your kidneys this drug may not be suitable.
Ribavirin
- Ribavirin alone does not cure hepatitis C but is used in
combination with other DAAs to increase their effect. The number of
tablets taken depends on weight and kidney function, and the number
of tablets taken can change during treatment.
- Side effects include fatigue (lack of energy), insomnia and
headache.
- This drug may not be suitable if you have heart problems or
some blood disorders or azathioprine. Ribavirin can cause birth
defects in animals and will not be prescribed.